Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Transforming the landscape of global financial regulatory rules through advanced technology aims to simplify the processes of identification and understanding, making financial regulation more accessible. With an emphasis on AI-driven compliance and effective change management, Finreg-E is at the forefront of this evolution. The platform utilizes machine learning and artificial intelligence to automatically identify crucial actions required by regulatory rules, establishing connections to internal controls while offering user-friendly workflows that address compliance gaps. Finreg-E stands out with its innovative application designed for regulatory compliance and change management, employing cutting-edge technology to enhance efficiency in the identification, analysis, and adherence to global financial regulations. By leveraging state-of-the-art tools such as natural language processing, topic modeling, and deep learning, Finreg-E seamlessly aligns regulatory mandates with internal policies and practices. This comprehensive approach not only streamlines compliance efforts but also ensures organizations remain agile in a constantly changing regulatory environment.
Description
Rhizome serves as an AI regulatory collaborator specifically designed for teams in the life sciences sector. While general AI assistants offer remarkable capabilities, there are distinct requirements for an AI tool that aids in making decisions regarding drugs or devices worth over $100 million.
Our agents are strictly limited to referencing facts derived from primary source documents, ensuring that nothing is validated based on agent memory; we assess their performance based on this criterion, and there have been no instances of inaccuracies reported in the past 18 months.
The databases that underpin regulatory decisions, including Drugs@FDA, guidance documents, clinicaltrials.gov, and various standards, often exist in formats that are not easily searchable by computers, with a significant amount being image-only PDFs. We have developed the ability to ingest and process all of this information, encompassing over 75 health authority databases across more than 12 markets as of August 2026, with this number continually growing. This equates to over 45 million documents that our agents can query comprehensively.
In contrast to a general assistant, which typically references 5 to 10 sources, Rhizome is capable of examining hundreds to thousands of documents, as the essential question is often, "Did we overlook a precedent?" This thorough approach ensures that our users are equipped with the most comprehensive and accurate information possible.
API Access
Has API
No
API Access
Has API
No
Integrations
ChatGPT
No
Claude
No
Microsoft 365 Copilot
No
Pricing Details
No price information available.
Free Trial
Yes
Free Version
No
Pricing Details
$0/month/user
Free Trial
No
Free Version
Yes
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
Yes
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
Yes
Vendor Details
Company Name
Finreg-E
Country
United Kingdom
Website
www.finreg-e.com
Vendor Details
Company Name
Rhizome AI
Founded
2023
Country
United States
Website
rhizomeai.com